LogicBio Therapeutics, Inc. Lease, Cost
LogicBio Therapeutics, Inc. reported Lease, Cost of $609.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-11-14
- LogicBio Therapeutics, Inc. lease, cost for the quarter ending 2022-09-30 was $609.00K, a 3.92% increase year-over-year.
- LogicBio Therapeutics, Inc. lease, cost for the quarter ending 2022-06-30 was $593.00K, a 0.17% decline year-over-year.
- LogicBio Therapeutics, Inc. lease, cost for the quarter ending 2022-03-31 was $601.00K, a 1.35% increase year-over-year.
- LogicBio Therapeutics, Inc. lease, cost for the quarter ending 2021-12-31 was $594.00K, a 0.17% increase year-over-year.
- LogicBio Therapeutics, Inc. lease, cost for fiscal 2021 was $2.37M, a 1.98% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. lease, cost for fiscal 2020 was $2.32M, a 50.91% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. lease, cost for fiscal 2019 was $1.54M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $609.00K 10-Q · filed 2022-11-14 | $1.20M derived: sum of 2 quarters · filed 2022-11-14 | $1.80M 10-Q · filed 2022-11-14 | $2.40M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $593.00K 10-Q · filed 2022-08-15 | $1.19M 10-Q · filed 2022-08-15 | $1.79M derived: sum of 3 quarters · filed 2022-08-15 | $2.37M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $601.00K 10-Q · filed 2022-05-16 | $1.20M derived: sum of 2 quarters · filed 2022-05-16 | $1.78M derived: sum of 3 quarters · filed 2022-11-14 | $2.38M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $1.18M derived: sum of 2 quarters · filed 2022-11-14 | $1.77M derived: sum of 3 quarters · filed 2022-11-14 | $2.37M 10-K · filed 2022-03-04 |
| 2021-09-30 | $586.00K 10-Q · filed 2022-11-14 | $1.18M derived: sum of 2 quarters · filed 2022-11-14 | $1.77M 10-Q · filed 2022-11-14 | $2.37M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $594.00K 10-Q · filed 2022-08-15 | $1.19M 10-Q · filed 2022-08-15 | $1.78M derived: sum of 3 quarters · filed 2022-08-15 | $2.44M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $593.00K 10-Q · filed 2022-05-16 | $1.19M derived: sum of 2 quarters · filed 2022-05-16 | $1.84M derived: sum of 3 quarters · filed 2022-05-16 | $2.49M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $1.25M derived: sum of 2 quarters · filed 2022-03-04 | $1.90M derived: sum of 3 quarters · filed 2022-03-04 | $2.32M 10-K · filed 2022-03-04 |
| 2020-09-30 | $655.00K 10-Q · filed 2021-11-15 | $1.30M derived: sum of 2 quarters · filed 2021-11-15 | $1.73M 10-Q · filed 2021-11-15 | $2.13M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $650.00K 10-Q · filed 2021-08-09 | $1.07M 10-Q · filed 2021-08-09 | $1.48M derived: sum of 3 quarters · filed 2021-08-09 | $1.89M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $423.00K 10-Q · filed 2021-05-10 | $826.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.24M derived: sum of 3 quarters · filed 2021-05-10 | $1.65M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $815.00K derived: sum of 2 quarters · filed 2021-03-15 | $1.22M derived: sum of 3 quarters · filed 2021-03-15 | $1.54M 10-K · filed 2021-03-15 |
| 2019-09-30 | $412.00K 10-Q · filed 2020-11-09 | $819.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.14M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $407.00K 10-Q · filed 2020-08-10 | $723.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $316.00K 10-Q · filed 2020-05-11 |